Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease ...

A new review explores how TMAO, a gut-derived metabolite from red meat and other foods, contributes to heart and brain ...

The lobate shape of lymphatic endothelial cells puzzled researchers—now they’ve found it helps stabilize lymphatic ...

Certain cells have an unusual shape that is similar to an oak leaf or puzzle piece, and researchers have found that the form of these cells ... | Cell And Molecular Biology ...

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

The vascular model was coated with fibronectin and immersed in a tube filled with a cell suspension of endothelium ... study was conducted using perfusion conditions used in the flow experiment. The ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

Info-Tech Research Group, a global IT research and advisory firm, has announced the first round of featured speakers for Info-Tech LIVE 2025 in Las Vegas, the firm's annual IT conference. Returning to ...

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan and security agreement with Hercules Capital ...

Angiosarcoma is a rare and aggressive malignant neoplasm that arises from endothelial cells of blood or lymphatic vessels, ...

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further ...

Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...